SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-000832
Filing Date
2019-08-20
Accepted
2019-08-20 08:31:14
Documents
13
Period of Report
2019-08-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv527995_8k.htm   iXBRL 8-K 26059
2 EXHIBIT 10.1 tv527995_ex10-1.htm EX-10.1 69835
  Complete submission text file 0001410578-19-000832.txt   277820

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA selb-20190819.xsd EX-101.SCH 3193
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE selb-20190819_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE selb-20190819_pre.xml EX-101.PRE 21963
6 EXTRACTED XBRL INSTANCE DOCUMENT tv527995_8k_htm.xml XML 3602
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 191037892
SIC: 2834 Pharmaceutical Preparations